Causes of Hyponatremia, Hyperkalemia, Hypovolemia, and High Anion-Gap Metabolic Acidosis in Infants
In infants presenting with this constellation of findings (hyponatremia, hyperkalemia, hypovolemia, and high anion-gap metabolic acidosis with normal glucose), the primary causes are congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency and secondary pseudohypoaldosteronism (PHA) associated with urinary tract infections, with CAH being the most common inherited cause and secondary PHA being a critical transient condition to recognize.
Primary Differential Diagnosis
Aldosterone Deficiency States (Primary Hypoaldosteronism)
The most common cause in this clinical scenario is congenital adrenal hyperplasia due to 21-hydroxylase deficiency, which accounts for approximately 84% (32/38) of primary hypoaldosteronism cases presenting with hyperkalemia in young children 1. This represents the most common inherited disorder of aldosterone synthesis and presents with life-threatening electrolyte disturbances in the first weeks of life 2.
Additional primary hypoaldosteronism causes include:
- Isolated hypoaldosteronism from CYP11B2 gene mutations 1
- Xp21 contiguous gene deletion syndrome 1
- Primary adrenal insufficiency from other etiologies 1
Aldosterone Resistance (Pseudohypoaldosteronism)
Secondary pseudohypoaldosteronism associated with urinary tract infections is a critical transient renal tubular dysfunction that occurs specifically in infants with infectious renal parenchymal involvement 3, 4. This condition presents with:
- Hyponatremia
- Hyperkalemia
- Metabolic acidosis
- Markedly elevated serum renin AND aldosterone levels (distinguishing it from primary hypoaldosteronism) 4
- Renal tubular unresponsiveness to aldosterone 3
This is particularly important because it can present with life-threatening shock and respiratory failure requiring mechanical ventilation 4, yet it is completely reversible with treatment of the underlying infection.
Primary PHA types include:
- PHA type 1 (NR3C2 gene mutations) 1
- PHA type 2 (CUL3 or KLHL3 gene mutations) 1
- PHA type 3 (secondary to urinary or intestinal tract pathologies) 1
High Anion-Gap Metabolic Acidosis Contributors
While the hyperkalemia and hyponatremia point toward aldosterone defects, the high anion-gap component requires additional consideration:
In the context of severe dehydration from gastroenteritis (which can coexist), high anion-gap acidosis results from:
- Elevated lactate (mean 3.4 ± 0.7 mmol/L) 5
- Elevated phosphate (mean 2.3 ± 0.2 mmol/L) 5
- Elevated total protein from hemoconcentration 5
- Elevated creatinine from prerenal azotemia 5
This contrasts with hyperchloremic normal anion-gap acidosis seen in simple diarrheal losses 5.
Diagnostic Algorithm
Step 1: Measure plasma aldosterone and renin levels
- Elevated aldosterone + elevated renin = Aldosterone resistance (PHA) 4
- Low aldosterone + elevated renin = Primary hypoaldosteronism (CAH most likely) 1
Step 2: If aldosterone resistance suspected, evaluate for UTI
- Urine culture and sensitivity 4
- Renal ultrasound to assess for vesicoureteral reflux or obstructive uropathy 2
Step 3: If primary hypoaldosteronism suspected
- 17-hydroxyprogesterone level (elevated in 21-hydroxylase deficiency)
- ACTH stimulation test
- Molecular genetic analysis for definitive diagnosis 1
Step 4: Assess anion gap contributors
- Lactate level
- Creatinine and BUN
- Phosphate level
- Consider organic acid screening if anion gap remains unexplained 6
Critical Management Pitfall
A normal plasma aldosterone level does NOT rule out an aldosterone defect in either biosynthesis or function, especially in young infants 1. This is a crucial caveat that can lead to missed diagnoses if clinicians rely solely on aldosterone levels for screening.
Treatment Implications
For secondary PHA associated with UTI, isotonic solutions (0.9% saline or lactated Ringer's) correct not only the volume depletion but also the hyperkalemia and acidosis 3. This is because correcting the volume status and treating the infection resolves the renal tubular unresponsiveness to aldosterone, making this a completely reversible condition.
For primary hypoaldosteronism (CAH), lifelong mineralocorticoid and glucocorticoid replacement is required, with acute management including volume resuscitation and correction of life-threatening hyperkalemia.